Cash Flow from Operating Activities: A company's cash flows from operations.
Channel Therapeutics Corporation (CHRO) had Cash Flow from Operating Activities of $-0.63M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.97M |
|
-- |
|
-- |
|
$1.83M |
|
$-1.83M |
|
$-0.13M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.83M |
|
$-1.74M |
|
6.13M |
|
6.13M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$0.91M |
|
-- |
|
-- |
|
$0.91M |
|
$5.11M |
|
-- |
|
-- |
|
$5.11M |
|
$-4.20M |
|
$-4.20M |
|
$-4.20M |
|
6.18M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-0.63M |
-- |
|
$0.25M |
|
$0.51M |
|
$0.13M |
|
$-0.38M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-0.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
46.89% |
|
46.89% |
|
-215.94% |
|
46.89% |
|
$-0.68 |
|
$-0.10 |
|
$-0.10 |
|